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Background: Vitamin D deﬁciency is commonly seen in patients with inﬂammatory bowel
disease (IBD). Vitamin D deﬁciency in IBD patients with ileostomy has not been systemically
studied. The aim of the study was to assess the frequency and risk factors associated with
low  25(OH) D3 levels in those patients.
Methods: 112 eligible IBD patients with ileostomy were studied. Demographic, clinical, and
endoscopic variables were analyzed. Vitamin D levels before and after ileostomy were com-
pared when available. Levels of serum 25(OH)D3 <20 ng/mL were classed as being deﬁcient.
Results: 112 eligible ileostomy patients were included. The mean vitamin D level was
21.47 ± 1.08 ng/dl. Low levels of vitamin D (<30 ng/dl) were present in 92 patients (82%). Vita-
min  D deﬁciency (<20 ng/dL) was seen in 55 patients (49%). There was no difference between
patients with or without vitamin D deﬁciency regarding demographic variables, medication
use  and duration of ileostomy. Neo-ileal inﬂammation on endoscopy was not associated
with  vitamin D deﬁciency (p = 0.155). Lower levels of phosphorus (p = 0.020) or hemoglobin
(p  = 0.019) and shorter duration of IBD (p = 0.047) were found in patients with vitamin D
deﬁciency. In multivariate analysis, lower levels of phosphorus (odds ratio [OR]: 1.83, 95%
conﬁdence interval [CI]: 1.16–2.89, p = 0.009) and hemoglobin (OR: 1.32, 95% CI: 1.08–1.60,
p  = 0.006) remained signiﬁcantly associated with vitamin D deﬁciency.
Conclusion: Vitamin D deﬁciency is common in IBD patients with ileostomy and is associated
with  low hemoglobin levels. Further studies are needed to evaluate vitamin D supplemen-
tation as a possible adjuvant in the treatment of anemia of chronic disease in IBD patients.©  2015 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. All
rights reserved.∗ Corresponding author.
E-mail: shenb@ccf.org (B. Shen).
ttp://dx.doi.org/10.1016/j.jcol.2015.06.004
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Associac¸ão  entre  deﬁciência  de  vitamina  D  e  anemia  em  pacientes  com
doenc¸a  inﬂamatória  intestinal  submetidos  a  ileostomia
Palavras-chave:
Anemia
Ileostomia
Deﬁciência de Vitamina D
r  e  s  u  m  o
Introduc¸ão: A deﬁciência de vitamina D em pacientes com doenc¸a inﬂamatória intestinal
submetidos a ileostomia não foi estudada sistematicamente. O objetivo desse estudo foi
avaliar a frequência e os fatores de risco associados com a deﬁciência de vitamina D nesses
pacientes.
Resultados: 112 pacientes elegíveis foram incluídos. A média dos níveis de vitamina D
na  populac¸ão estudada foi de 21.47 ± 1.08 ng/dl. Níveis de vitamina D abaixo do normal
(<30  ng/dl) e deﬁciência de vitamina D (<20 ng/dL) foram encontrados em 92 pacientes (82%)
e  em 55 pacientes (49%) respectivamente. Encontrou-se uma associac¸ão entre deﬁciência
de vitamina D e níveis mais baixos de fosforo (p = 0.020), hemoglobina (p = 0.019) e durac¸ão
da  doenc¸a inﬂamatória intestinal (p = 0.047). Na análise multivariada, níveis mais baixos de
fósforo (odds ratio [OR]: 1.83, 95% conﬁdence interval [CI]: 1.16–2.89, p = 0.009) e hemoglobina
(OR:  1.32, 95% CI: 1.08–1.60, p = 0.006) permaneceram associados com deﬁciência de vitamina
D.
Conclusão: A deﬁciência de vitamina D é comum em pacientes com doenc¸a inﬂamatória
intestinal submetidos a ileostomia e está associada com níveis baixos de hemoglobina.
Mais estudos são necessários para avaliar se a suplementac¸ão de vitamina D pode ser um
adjuvante no tratamento de anemia da doenc¸a crônica nesses pacientes.
©  2015 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda.
Todos os direitos reservados.Introduction
Vitamin D is a steroid hormone responsible for calcium
hemostasis and metabolism. It also has immunoregula-
tory functions and anti-inﬂammatory effects.1 The main
source of vitamin D derives from the conversion of 7-
dehydrocholesterol in the skin to cholecalciferol (D3) by
sunlight. Vitamin D is also acquired from the diet and it is
absorbed in the duodenum and jejunum. As a liposoluble vita-
min, it depends on bile acids for its absorption. The bile acid
pool is maintained by the enterohepatic circulation and relays
on the absorption of bile acids in the terminal ileum.
Vitamin D deﬁciency is common worldwide. In the United
States, the reported frequency of vitamin D deﬁciency is
18–40% in adult females and 11–26% in adult males, with vari-
ation depending on age, season and geographical location.2
Vitamin D deﬁciency has a signiﬁcant impact on health,
including low bone mineral density, increased risk of fractures
and falls.3 In addition, adequate blood vitamin D levels and
intake of vitamin D may decrease the risk of cancer,4 type I
diabetes,5 multiple sclerosis6 and rheumatoid arthritis.7
Low vitamin D levels are common in patients with inﬂam-
matory bowel disease (IBD), occurring in 45–63% of the
patients.8,9 The mechanisms for vitamin D deﬁciency in IBD
patients are multifactorial. Patients with IBD are subject to
surgery, particularly ileal resection for Crohn’s disease, and
may be at increased risk of vitamin D deﬁciency. IBD patients
often require surgery during the course of their disease10 and
ileostomy is performed in a subset of patients with CD or
ulcerative colitis (UC).11
Surgical procedures such as ileostomy may pose an addi-
tional risk for vitamin D deﬁciency in IBD patients. Studiesevaluating the rates and associated risk factors of vitamin D
deﬁciency in this population are lacking. Thus the aims of this
study were to evaluate the frequency of vitamin D deﬁciency
in IBD patients with an ileostomy and to identify risk factors
for vitamin D deﬁciency in these patients.
Patients  and  methods
Patients
This study was approved by the Cleveland Clinic Institutional
Review Board (IRB). Three hundred IBD patients with per-
manent ileostomy were retrospectively identiﬁed from the
electronic medical records. A total of 112 patients with IBD
and at least one serum 25(OH)D3 level after the construction of
ileostomy were included in the study. Inclusion criteria were:
(1) diagnosis of IBD; (2) the presence of permanent or tem-
porary ileostomy; and (3) at least one serum 25(OH)D3 level
measured after the ostomy. Exclusion criteria were ileostomy
for bowel malignancy or for familial adenomatous polyposis
or etiologies other than IBD.
Variables
A total of 32 demographic, clinical and endoscopic variables
were studied. Demographic variables included age, gender,
race, body mass index (BMI), smoking status and geographical
location (North vs. South). The Northern location was deﬁned
as location above the latitude of 37 degrees North. The South-
ern location was deﬁned as a location below the latitude of 37
degrees North.
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The following clinical variables were included: duration of
isease, duration of disease until submission to ileostomy,
uration of ileostomy, season when vitamin D was mea-
ured and clinical indication for ileostomy and blood levels
f 25(OH)D3, albumin, hemoglobin (Hb), calcium, parathyroid
ormone (PTH), alkaline phosphatase and C-reactive pro-
ein (CRP). History of use of calcium supplements, vitamin
upplements, corticosteroid, immunomodulators, anti-tumor
ecrosis factor (TNF) biologics, antibiotics or non-steroidal
nti-inﬂammatory drugs (NSAID) were also evaluated. Endo-
copic variables included the presence or absence of any
ucosal inﬂammation on ileoscopy.
Vitamin D status was assessed by measuring the most
ecent 25(OH)D3 level. Vitamin D levels ≥ 30 ng/mL were con-
idered normal. A low vitamin D was deﬁned as the level
elow 30 ng/mL. Low vitamin D levels were further categorized
nto vitamin D insufﬁciency when levels were between 20 and
9 ng/dl and vitamin D deﬁciency when levels were less than
0 ng/dl.
To evaluate the presence of anemia, the most recent Hb
evel within 6 months of vitamin D level measurement was
aken into account. Anemia was deﬁned as Hb <12.0 g/dL in
emales and Hb <13 g/dL in males. The presence of iron deﬁ-
iency anemia (IDA) and anemia of chronic disease (ACD) was
eﬁned based on serum iron levels, transferrin, transferrin
aturation and ferritin. The deﬁnition of ACD and IDA was
s follows according to Weiss and Goodough12: (1) transferrin
aturation <16% with normal or elevated serum ferritin lev-
ls (>100 ng/mL) characterized as ACD; (2) low levels of both
ransferrin saturation (<16%) and serum ferritin (<30 ng/mL)
haracterized as IDA. Transferrin saturation <16%, reduced
ransferrin concentration, and serum ferritin >30 ng/mL but
100 ng/mL characterized a mixed pattern of IDA and ACD.
utcome  measurements
he primary outcomes were the frequency and risk factors of
itamin D deﬁciency in IBD patients with ileostomy.
tatistical  analysis
ll statistical analyses were performed using SPSS software
ersion 22 (IBM Corp., Armonk, NY). Mean ± SD or n% was used
o present continuous variables. To identify potential risk fac-
ors for vitamin D deﬁciency, univariable analysis was used.
tudent’s t test (or Wilcoxon rank sum test when appropri-
te) was used for continuous variables, while Chi-square test
or Fishers exact test, when appropriate) was used for cat-
gorical variables. Variables that were signiﬁcantly (p < 0.05)
ssociated with vitamin D deﬁciency on univariate analysis
ere included in the multivariate analysis along with vari-
bles previously shown in the literature to affect vitamin D
evels.
esults total of 112 eligible patients with IBD and ileostomy were
ncluded in this study, of which 107 had CD and 5 had UC.
he mean age of the cohort studied was 53.4 ± 1.3 years (range;3 5(3):139–145 141
24–91 years) and 70 (62.5%) patients were females. The mean
duration of IBD diagnosis was 24.6 ± 1.2 years (range 2–60
years) and the mean duration of ileostomy was 12.7 ± 0.9
years (range 2–45 years). The main indications for ileostomy
in the cohort were failure of medical therapy in 90 patients
(80.4%) and bowel obstruction in 22 (19.6%). In the subgroup
of patients with UC, the main indication for end ileostomy
was complications of the ileal pouch (3/5). Five patients had
temporary ileostomy and 107 had permanent ileostomy.
Frequency  of  vitamin  D  deﬁciency
The mean vitamin D level of the whole cohort was
21.47 ± 1.08 ng/dl. Low vitamin D (<30 ng/dl) levels were
present in 92 (82.1%) patients. Thirty-seven patients (33.0%)
were classiﬁed as having vitamin D insufﬁciency (level
between 20 and 29 ng/dl) and 55 (49.1%) as vitamin D deﬁciency
(<20 ng/dl).
We  performed a subanalysis of the trend of vitamin D
status before and after ileostomy, based on available data
in 26 (23.2%) of the 112 patients. The mean level of vita-
min  D was signiﬁcantly higher after ileostomy compared to
before ileostomy (22.4 ± 1.8 ng/dL, vs. 17.5 ± 1.8 ng/dL, p = 0.007)
as shown in Fig. 1.
Univariate  assessment  of  risk  factors  for  vitamin  D
deﬁciency
The 112 patients were divided into those with vitamin D deﬁ-
ciency (<20 ng/mL) and those without vitamin D deﬁciency
(>20 ng/mL) to analyze the risk factors associated with vitamin
D deﬁciency.
In the univariate analysis, levels of phosphorus were sig-
niﬁcantly lower in the vitamin D deﬁciency group (p < 0.020).
Numerically lower levels of calcium and higher levels of PTH
were also found in these patients although this did not reach
statistical signiﬁcance (Table 1).
In addition, Hb levels were signiﬁcantly lower in the vita-
min  D deﬁciency group (p = 0.019) (Table 1). A total of 47 (42.0%)
of the 112 were found to have anemia, deﬁned as Hb <12 ng/dL
in females and Hb <13 ng/dL in males. Among the 47 patients
with diagnosis of anemia, 37 had iron studies including iron
levels, transferrin, transferrin saturation and ferritin. ACD was
detected in 21 (63.6%) patients, IDA was detected in 6 (18.2%)
patients and mixed pattern anemia was also detected in 6
(18.2%) patients. No statistical difference was found between
patients with and without vitamin D deﬁciency regarding the
prevalence of the different types of anemia (ACD vs.  IDA vs.
mixed pattern anemia) (p = 0.204, Table 1).
Patients with vitamin D deﬁciency had IBD diagnosis for a
shorter period of time (p = 0.047), but no signiﬁcant differences
were found neither in the duration of ileostomy (p = 0.080), the
interval between IBD diagnosis (p = 0.819) and ileostomy nor
the presence of inﬂammation on ileoscopy (p = 0.155) as shown
in Table 1.
There was no difference in age, gender, race, BMI, smok-
ing status, geographical location, season when vitamin D
was measured, albumin, alkaline phosphatase, CRP, the
use of calcium supplements, vitamin supplements, steroid,
immunomodulators, anti-TNF biologics, antibiotics and
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Table 1 – Demographic, clinical, endoscopic and histologic characteristics of ileostomy patients with and without vitamin
D deﬁciency.
Variables All cases (total
112)
Vitamin
deﬁciency
(<20 ng/mL) n = 55
No vitamin D
deﬁciency
(≥20 ng/mL) n = 57
p-value
Mean age, years 53.39 ± 1.32 52.04 ± 1.87 54.87 ± 1.87 0.317a
Male gender 42 18 (32.7%) 24 (42.1%) 0.203b
BMI 26.19 ± 0.58 26.46 ± 0.94 25.94 ± 0.70 0.659a
Race, n%
Non-Hispanic 27 14(25.5%) 13 (22.8%) 0.827b
Caucasian 85 41 (74.5%) 44 (77.2%)
North state location 105 51 (92.7%) 54 (94.7%) 0.480b
Season, n%
Spring 26 11 (20.0%) 15 (26.3%)
0.598b
Summer 30 15 (27.3%) 15 (26.3%)
Fall 31 14 (25.5%) 17 (29.8%)
Winter 25 15 (27.3%) 10 (17.5%)
Smoking, n%
Current 21 14 (25.5%) 7 (12.3%)
0.146bQuit 33 13 (23.6%) 20 (35.1%)
Never 58 28 (50.9%) 30 (52.6%)
Excessive use of alcohol, n% 37  15 (27.3%) 22 (38.6%) 0.232b
Indication for stoma
Refractory IBD 90 43 (78.2%) 47 (82.5%)
0.971b
Mechanical obstruction 22 12 (21.8%) 10 (17.5%)
Years from IBD diagnosis 24.60 ± 1.24 22.09 ± 1.84 27.02 ± 1.62 0.047a
Years after ileostomy 12.72 ± 0.91 12.50 ± 1.37 12.92 ± 1.92 0.819a
Years between diagnosis and ileostomy 11.18 ± 1.07 9.27 ± 1.44 13.02 ± 1.54 0.080a
Ileal inﬂammation (ileoscopy) 26 10 (18.2%) 16 (28.1%) 0.266b
Use of steroids 83 39 (70.9%) 44 (77.2%) 0.520b
Use of aspirin 43 23 (41.8%) 20 (35.1%) 0.295b
Use of antibiotics 107 52 (94.5%) 55 (96.5%) 0.483b
Use of NSAIDS 62 31 (56.4%) 31 (54.4%) 0.492b
Use of biologics 49 20 (36.4%) 29 (50.9%) 0.132b
Use of immunomodulators 63 28 (50.9%) 35 (61.4%) 0.177b
Use of calcium 78 35 (63.6%) 43 (75.4%) 0.125b
Use of vitamin D 88 40 (72.7%) 48 (84.2%) 0.105b
Calcium 81.25 ± 1.83 77.75 ± 2.86 84.63 ± 2.23 0.060c
PTH 103.11 ± 14.01 111.64 ± 21.73 87.23 ± 16.78 0.512c
Phosphorus 3.35 ± 0.10 3.08 ± 0.10 3.58 ± 0.17 0.020c
Alkaline phosphatase 132.36 ± 9.06 143.73 ± 16.06 117.53 ± 8.46 0.096c
Hemoglobin 10.92 ± 0.22 10.38 ± 0.32 11.42 ± 0.30 0.019c
Anemia typed
Chronic disease 21 15 (75.0%) 6 (46.2%)
0.204b,cIron deﬁciency 6 2 (10.0%) 4 (30.8%)
Mixed pattern 6 3 (15.0%) 3 (23.1%)
Albumin 3.47 ± 0.08 3.37 ± 0.13 3.55 ± 0.15 0.429a
CRP > 1e 66 37 (67.3%) 29 (50.9%) 0.073b,c
BMI, body mass index; 5 ASA, 5-aminosalicylic acid; NSAID, non-steroidal anti-inﬂammatory drugs; PTH, parathyroid hormone.
a The p value was calculated by t-test.
b The p value was calculated by chi-square test.
c Some variables may have less than 112 due to missing data.
d Anemia type was available in 33 patients, 20 in vitamin D deﬁciency and 13 in no vitamin D deﬁciency groups.
e CRP was available in 104 patients, 50 in vitamin D deﬁciency and 54 in no vitamin D deﬁciency groups.
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on-steroidal anti-inﬂammatory drugs (NSAID), between the
tudy and control groups (Table 1).
ultivariate  analysis  of  risk  factors  for  vitamin  D
eﬁciency
ow Hb, low phosphorus level and shorter duration of IBD
iagnosis were signiﬁcantly associated with vitamin D deﬁ-
iency in the univariate analysis and thus were included in the
ultivariable analysis. When the effect of these variables was
nalyzed together in the logistic regression, low Hb (odds ratio
OR]: 1.32, 95% conﬁdence interval [CI]: 1.08–1.60, p = 0.006)
nd low phosphorus (OR: 1.83, 95% CI: 1.16–2.89, p = 0.009)
emained independently associated with vitamin D deﬁciency
Table 2).
iscussion
n this study, we  found that the low vitamin D levels (vitamin D
eﬁciency or insufﬁciency) were common in IBD patients with
leostomy, with a frequency of 82.1% (92/112). Surprisingly,
itamin D status improved after ileostomy, when compared
ith pre-ileostomy status, based on the data in 26 patients
ith sequential measurements of serum vitamin D level.
Table 2 – Multivariate analysis of risk factors associated with vi
Variables OR 
Low phosphorus 1.83 
Low hemoglobin 1.32 
Years from IBD diagnosis 1.04 
OR, odds ratio; CI, conﬁdence interval.vels before and after ileostomy (N = 26).
Vitamin D deﬁciency was found to be associated with ane-
mia  (p = 0.009), suggesting that there may be a link between
vitamin D deﬁciency and anemia in these patients. In the 33
patients who had available data for anemia type identiﬁcation,
ACD was more  prevalent in patients with vitamin D deﬁciency
than controls (66.7% vs. 33.3%), although this ﬁnding did not
reach statistical signiﬁcance (p = 0.204). There was no associ-
ation between vitamin D deﬁciency and ileum inﬂammation
on ileoscopy (p = 0.155).
Low vitamin D levels are common in patients with IBD in
general.7 Up to 63% of patients with CD have vitamin D deﬁ-
ciency [39], while in patients with UC vitamin D deﬁciency
has been shown to occur in 45% of the cases.7 In both CD and
UC, severity of disease was found to be associated with vita-
min D deﬁciency.13,14 Since vitamin D has been shown to have
anti-inﬂammatory properties, its lower level may predispose
to greater inﬂammation and disease activity in both CD and
UC, creating a vicious circle.15,16 Our study showed that the
creation of an ileostomy may help boost the level of serum
vitamin D, presumably due to the bypass or resection of the
diseased bowel downstream.The cause of vitamin D deﬁciency in IBD patients appears
to be multifactorial, including decreased sun exposure17 and
decreased dietary vitamin D intake due to the disease.18
In patients with CD, additional culprits are vitamin D
tamin D deﬁciency in IBD patients with ileostomy.
CI p-value
1.16–2.89 0.009
1.08–1.60 0.006
1.00–1.07 0.051
j). 2 0144  j coloproctol (rio 
malabsorption and protein losing enteropathy causing loss
of vitamin D binding protein.19 Terminal ileum resection in
patients CD has also been proposed as a contributor to vita-
min D deﬁciency due to decreased enterohepatic circulation
of bile acids.20
Surgical approach in patients with IBD such as end
ileostomy imposes additional metabolic consequences to an
already burdened population. In IBD patients with ileostomy,
our group has previously shown a high prevalence of low
bone mineral density, further complicated by increased risk
of fractures.21 There may be an increased risk of vitamin B12
deﬁciency in these patients, although this seems to be more
common when signiﬁcant amounts of ileum are resected.22
In addition, there is an increased fecal excretion of choles-
terol and bile acids in patients with ileostomy, which has been
shown to improve cholesterol proﬁle in these patients, while
it may further impair bile acid enterocirculation.23 The associ-
ation between vitamin D deﬁciency and anemia, on the other
hand, has not been established in this population.
To our knowledge, this is the ﬁrst study evaluating vita-
min D deﬁciency and its risk factors in IBD patients with
ileostomy. Kennedy et al.24 studied calcium metabolism in
49 patients with ileostomy and mentioned that the levels
of vitamin D in these patients varied from 21.4 ± 9.5 nmol/L
in the winter to 46.4 ± 19.2 nmol/L in the summer. However,
risk factors for vitamin D deﬁciency were not evaluated. In
the present study, vitamin D deﬁciency was common in IBD
patients submitted to ileostomy. The exact etiopathogene-
sis for vitamin D deﬁciency in IBD patients with ileostomy
is unknown. We  postulate that it may be related to altered
intestinal transit time and ileal resection in this population.
Some IBD patients with ileostomy may have extensive inﬂam-
mation or strictures, which leads to stasis of fecal content in
the small bowel and bacterial overgrowth.25 In turn, bacterial
overgrowth causes deconjugation of bile acids and decreases
the absorption of fat soluble vitamins such as vitamin D.26
Ileostomy with ileal resection in CD may lead to impaired bile
acid enterohepatic circulation. In patients with ileal CD, lower
vitamin D levels seem to be more  common.20
To better understand the exact burden that ileostomy poses
toward vitamin D deﬁciency, we compared the levels of vita-
min  D before and after ileostomy in 26 patients with available
data. Surprisingly, the mean level of vitamin D was signif-
icantly lower before ileostomy than after ileostomy. These
ﬁndings may be a consequence of better disease control
or less inﬂammation leading to nutritional improvement in
IBD patients after ileostomy. In addition, after surgery these
patients may have improved oral intake and increased quality
of life with more  outdoor activity.
Interestingly, we  found a signiﬁcant association between
low vitamin D and Hb in both univariable and multivariate
analyses. This ﬁnding, along with the similar one reported
in patients with ileal pouch-anal anastomosis (IPAA),27
prompted our hypothesis that the link between vitamin D deﬁ-
ciency and anemia is not a coincidence. This association has
not yet been studied in IBD patients without ileostomy or IPAA.
A total of 37 patients had available laboratory data to further
categorize the subtype of anemia into ACD, IDA or mixed pat-
tern. ACD was the most common type of anemia in the cohort,
occurring in 21 patients (66.6%). Although ACD occurred more 1 5;3  5(3):139–145
frequently in patients with vitamin D deﬁciency, this did not
reach statistical signiﬁcance (75.0% vs. 46.2%, p = 0.204), prob-
ably due to the small sample size.
The association of vitamin D deﬁciency with anemia has
been demonstrated in patients with and without chronic kid-
ney disease.28,29 In the elderly, vitamin D deﬁciency seems to
be associated with ACD, but not with other types of anemia,
pointing toward a possible role of vitamin D in inﬂammation
suppression.28 Vitamin D deﬁciency was signiﬁcantly associ-
ated with a high hepcidin level, a pro-inﬂammatory mediator
and a player in iron metabolism. Hepcidin may play a role in
ACD in CD.30 We therefore attempted to connect the dots. We
postulate that vitamin D deﬁciency is linked to anemia in IBD
patients, speciﬁcally ACD, through the inﬂammation-hepcidin
axis. Whether vitamin D deﬁciency contributes to increased
inﬂammation leading to ACD or whether both vitamin D
deﬁciency and anemia are a common end of a chronic inﬂam-
matory state is unknown. Prospective, longitudinal studies are
needed to further sort out the association or causal relation-
ship.
Although the presence of inﬂammation in the ileum diag-
nosed by ileoscopy could potentially be predisposed to low
vitamin D levels by further impairing absorption of bile acids
and vitamin D through the inﬂamed mucosa, this was not
conﬁrmed in by our study. This may indicate that the most
important factor for vitamin D deﬁciency in these patients
is disruption of the anatomy. Similar ﬁndings of low vitamin
D levels in IBD patients with IPAA without correlation with
inﬂammation on endoscopy or histology have been described
in the literature.27 Alternatively, this may imply that con-
ditions such as ileostomy and IPAA cause a reset of the
immunostat, interfering with nutrition and metabolism.
There are several clinical implications of the ﬁndings in
this study. Vitamin D deﬁciency is common in patients with
ileostomy and vitamin D levels should be routinely measured
in these patients. In addition, we  suggest that Hb levels should
be checked when vitamin D deﬁciency is encountered and vice
versa. In addition, there may be a role for vitamin D supple-
mentation through immunomodulation in the treatment of
ACD in this patient population, warranting future studies for
conﬁrmation.
This study has limitations. First, the sample size may limit
the power of the study, particularly the analysis of anemia.
Second, the rate of vitamin D deﬁciency may reﬂect greater
disease severity of the IBD patient population in our tertiary
center and may not represent the IBD population in general,
resulting in referral bias. Because this is a retrospective study,
data on levels of vitamin D and anemia before and after the
ileostomy were lacking in some patients, as checking of vita-
min  D before ileostomy has not been a part of routine clinical
practice. Further studies conﬁrming the association of vitamin
D deﬁciency with anemia subtypes in IBD patients indepen-
dent of surgical status may be of interest. In addition, it may
be interesting to compare different doses of vitamin D supple-
mentation in patients with ileostomy in the future to establish
if vitamin D supplementation can ameliorate not only the
vitamin D deﬁciency but also anemia in IBD patients with
ileostomy.
In conclusion, vitamin D deﬁciency is common in IBD
patients with ileostomy irrespective of inﬂammation on
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ndoscopy or histology and is associated with anemia,
atients with IBD and anemia should be routinely screened
or vitamin D deﬁciency and vice versa. Vitamin D deﬁciency
ay play a role in ACD.
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